In vivo gene delivery to articular chondrocytes mediated by an adeno‐associated virus vector

[1]  Michael D Maloney,et al.  Articular Cartilage Biology , 2003, The Journal of the American Academy of Orthopaedic Surgeons.

[2]  E. Schwarz,et al.  Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes. , 2002, Arthritis and rheumatism.

[3]  G. Blancho,et al.  Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  M. Hallek,et al.  Real-Time Single-Molecule Imaging of the Infection Pathway of an Adeno-Associated Virus , 2001, Science.

[5]  S. Gay,et al.  Designing novel therapeutic strategies for rheumatic diseases. , 2001, Trends in immunology.

[6]  P. Robbins,et al.  Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  M. Galloway,et al.  Management of osteochondral injuries of the knee. , 2001, Clinics in sports medicine.

[8]  C. Jorgensen,et al.  Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis , 2001, Annals of the rheumatic diseases.

[9]  K. Cheah,et al.  Chondrocyte antigen expression, immune response and susceptibility to arthritis. , 2001, International immunology.

[10]  Freddie H. Fu,et al.  Treatment of osteochondral injuries. Genetic engineering. , 2001, Clinics in sports medicine.

[11]  O. Danos,et al.  Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome Degradation , 2001, Journal of Virology.

[12]  R. Samulski,et al.  Building a better vector: the manipulation of AAV virions. , 2000, Virology.

[13]  R. Samulski,et al.  Adeno-associated virus vectors for gene therapy: more pros than cons? , 2000, Molecular medicine today.

[14]  E. Schwarz.  The adeno-associated virus vector for orthopaedic gene therapy. , 2000, Clinical orthopaedics and related research.

[15]  P. Robbins,et al.  Using gene therapy to protect and restore cartilage. , 2000, Clinical orthopaedics and related research.

[16]  D. Frisbie,et al.  Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis. , 2000, Clinical orthopaedics and related research.

[17]  G. Boivin,et al.  Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  T. Branch,et al.  Surgical Alternatives for Treatment of Articular Cartilage Lesions , 2000, The Journal of the American Academy of Orthopaedic Surgeons.

[19]  Y. Hirasawa,et al.  Gene delivery to human chondrocytes by an adeno associated virus vector. , 2000, The Journal of rheumatology.

[20]  G. Kollias,et al.  Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. , 2000, The Journal of rheumatology.

[21]  I. Verma,et al.  Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  P. D. Di Cesare,et al.  Degradation and repair of articular cartilage. , 1999, Frontiers in bioscience : a journal and virtual library.

[23]  C. Malemud.  Fundamental pathways in osteoarthritis: an overview. , 1999, Frontiers in bioscience : a journal and virtual library.

[24]  V. Goldberg,et al.  Future directions for research and treatment of osteoarthritis. , 1999, Frontiers in bioscience : a journal and virtual library.

[25]  M. Takigawa,et al.  Direct adenovirus-mediated gene delivery to the temporomandibular joint in guinea-pigs. , 1999, Archives of oral biology.

[26]  Y. Tsao,et al.  Disease-Inducible Transgene Expression from a Recombinant Adeno-Associated Virus Vector in a Rat Arthritis Model , 1999, Journal of Virology.

[27]  D. Duan,et al.  Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction. , 1999, Human gene therapy.

[28]  Y. Hirasawa,et al.  Adenovirus mediated gene delivery to the joints of guinea pigs. , 1998, The Journal of rheumatology.

[29]  R. Samulski,et al.  Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus , 1998, Journal of Virology.

[30]  H. Häuselmann.  Mechanisms of cartilage destruction and novel nonsurgical therapeutic strategies to retard cartilage injury in rheumatoid arthritis. , 1997, Current opinion in rheumatology.

[31]  James M. Wilson,et al.  Recombinant adeno-associated virus for muscle directed gene therapy , 1997, Nature Medicine.

[32]  D. Russell,et al.  Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Samulski,et al.  Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector , 1996, Journal of virology.

[34]  T. Samulski,et al.  Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors , 1996, Journal of virology.

[35]  D. Russell,et al.  Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. , 1996, Human gene therapy.

[36]  T. Flotte,et al.  In vivo model of adeno-associated virus vector persistence and rescue , 1996, Journal of virology.

[37]  G. Breese,et al.  Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector , 1996, Brain Research.

[38]  M. Weitzman,et al.  Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis , 1996, Journal of virology.

[39]  R. Heilbronn,et al.  DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. , 1988, Cancer research.

[40]  Freddie H Fu,et al.  Gene therapy and tissue engineering in orthopaedic surgery. , 2002, The Journal of the American Academy of Orthopaedic Surgeons.

[41]  K. Ozawa,et al.  Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors. , 2000, Journal of neural transmission. Supplementum.

[42]  C. T. Vangsness,et al.  Overview of treatment options for arthritis in the active patient. , 1999, Clinics in sports medicine.

[43]  L Hangody,et al.  Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete. Rationale, indications, techniques, and results. , 1999, Clinics in sports medicine.

[44]  Donald W. Pfaff,et al.  Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain , 1994, Nature Genetics.